| Company Name: |
Hangzhou MolCore BioPharmatech Co.,Ltd. |
| Tel: |
+86-057181025280; +8617767106207 |
| Email: |
sales@molcore.com |
| Products Intro: |
Product Name:2,2',2'-[1,3,5-Triazine-2,4,6-triyltris(oxy-4,1-phenylenecarbonyloxy)]tris[N,N,N-trimethylethanaminium] iodide (1:3)
CAS:1414469-59-2
Purity:NLT 98% Remarks:MC807410
|
|
|
|
|
|
| | 2,2′,2′-[1,3,5-Triazine-2,4,6-triyltris(oxy-4,1-phenylenecarbonyloxy)]tris[N,N,N-trimethyl-ethanaminium tri-iodide Basic information |
| Product Name: | 2,2′,2′-[1,3,5-Triazine-2,4,6-triyltris(oxy-4,1-phenylenecarbonyloxy)]tris[N,N,N-trimethyl-ethanaminium tri-iodide | | Synonyms: | 2,2′,2′-[1,3,5-Triazine-2,4,6-triyltris(oxy-4,1-phenylenecarbonyloxy)]tris[N,N,N-trimethyl-ethanaminium tri-iodide;TAE-1;TAE-1 >=98% (HPLC);2,2',2"-[1,3,5-Triazine-2,4,6-triyltris(oxy-4,1-
phenylenecarbonyloxy)]tris[N,N,N-trimethyl-
ethanaminium] triiodid;2,2',2'-[1,3,5-Triazine-2,4,6-triyltris(oxy-4,1-phenylenecarbonyloxy)]tris[N,N,N-trimethylethanaminium] iodide (1:3);β-amyloid peptide,inhibit,Cholinesterase (ChE),TAE1,Amyloid-β,TAE-1,Abeta,Inhibitor,TAE 1 | | CAS: | 1414469-59-2 | | MF: | C39H51I3N6O9 | | MW: | 1128.57045 | | EINECS: | | | Product Categories: | | | Mol File: | 1414469-59-2.mol | ![2,2′,2′-[1,3,5-Triazine-2,4,6-triyltris(oxy-4,1-phenylenecarbonyloxy)]tris[N,N,N-trimethyl-ethanaminium tri-iodide Structure](CAS/20180713/GIF/1414469-59-2.gif) |
| | 2,2′,2′-[1,3,5-Triazine-2,4,6-triyltris(oxy-4,1-phenylenecarbonyloxy)]tris[N,N,N-trimethyl-ethanaminium tri-iodide Chemical Properties |
| storage temp. | 2-8°C | | solubility | H2O: soluble5mg/mL, clear (warmed) | | form | powder | | color | white to beige |
| | 2,2′,2′-[1,3,5-Triazine-2,4,6-triyltris(oxy-4,1-phenylenecarbonyloxy)]tris[N,N,N-trimethyl-ethanaminium tri-iodide Usage And Synthesis |
| Biological Activity | tae-1 is an inhibitor of amyloid-β fibril formation and aggregation.alzheimer’s disease (ad), a progressive neurodegenerative disorder, is characterized by the cerebral accumulation of insoluble aggregates of amyloid-β peptides (aβ). although the precise mechanisms governing neuronal loss remains ambiguous, toxicity resulting from aβ-activated pathways is evident. | | in vitro | in a previous study, the authors examined the effects of tae-1 on differentiated human sh-sy5y neuronal cells grown in tissue culture. results showed that the stimulation of neuronal cellular process length and branching was noted. moreover, the increased synaptophysin suggested that tae-1 could stimulate synapse formation. increased expression of map2 was also observed, indicating that tae-1 promoted the differentiation of human neurons. in addition, targeted ache inhibition was evaluated by electrochemical quantification of the enzymatic product, thiocholine, on unmodified gold screen-printed electrodes. it was found that at increasing tae-1concentrations, there was a corresponding decrease in the ache activity resulting in reduced amount of oxidizable thiocholine. the ic50 value was found to be 0.465 μm for tae-1 [1]. | | IC 50 | 0.3 ± 0.02 μm for ache; 3.9 ± 0.2 μm for buche | | references | [1] veloso aj, chow am, dhar d, tang dw, ganesh hv, mikhaylichenko s, brown ir, kerman k. biological activity of sym-triazines with acetylcholine-like substitutions as multitarget modulators of alzheimer's disease. acs chem neurosci. 2013 jun 19;4(6):924-9. |
| | 2,2′,2′-[1,3,5-Triazine-2,4,6-triyltris(oxy-4,1-phenylenecarbonyloxy)]tris[N,N,N-trimethyl-ethanaminium tri-iodide Preparation Products And Raw materials |
|